- Home
- LOVE vs ALDX Comparison
LOVE vs ALDX Comparison
Compare LOVE & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOVE
- ALDX
- Stock Information
- Founded
- LOVE 1998
- ALDX 2004
- Country
- LOVE United States
- ALDX United States
- Employees
- LOVE N/A
- ALDX N/A
- Industry
- LOVE Other Specialty Stores
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- LOVE Consumer Discretionary
- ALDX Health Care
- Exchange
- LOVE Nasdaq
- ALDX Nasdaq
- Market Cap
- LOVE 280.7M
- ALDX 270.7M
- IPO Year
- LOVE 2018
- ALDX 2014
- Fundamental
- Price
- LOVE $18.37
- ALDX $5.26
- Analyst Decision
- LOVE Strong Buy
- ALDX Strong Buy
- Analyst Count
- LOVE 5
- ALDX 2
- Target Price
- LOVE $30.40
- ALDX $9.50
- AVG Volume (30 Days)
- LOVE 208.1K
- ALDX 1.2M
- Earning Date
- LOVE 09-11-2025
- ALDX 08-15-2025
- Dividend Yield
- LOVE N/A
- ALDX N/A
- EPS Growth
- LOVE N/A
- ALDX N/A
- EPS
- LOVE 0.82
- ALDX N/A
- Revenue
- LOVE $686,358,000.00
- ALDX N/A
- Revenue This Year
- LOVE $6.64
- ALDX N/A
- Revenue Next Year
- LOVE $7.24
- ALDX $29.89
- P/E Ratio
- LOVE $22.11
- ALDX N/A
- Revenue Growth
- LOVE N/A
- ALDX N/A
- 52 Week Low
- LOVE $12.12
- ALDX $1.14
- 52 Week High
- LOVE $39.49
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- LOVE 47.12
- ALDX 59.77
- Support Level
- LOVE $17.31
- ALDX $4.23
- Resistance Level
- LOVE $18.53
- ALDX $5.23
- Average True Range (ATR)
- LOVE 0.71
- ALDX 0.31
- MACD
- LOVE -0.09
- ALDX -0.10
- Stochastic Oscillator
- LOVE 30.27
- ALDX 61.75
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.